EcoDrugPlus

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLCAG00010022446
Gene Symbol: AVPR2
2 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSLCAG00010004693
Gene Symbol: LOC108887913
4 Cross references
249 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSLCAG00010004080
Gene Symbol: AURKA
4 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSLCAG00010022522
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSLCAG00010013216
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSLCAG00010018411
Gene Symbol: LOC108874844
4 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCAG00010018415
Gene Symbol: BDKRB2
1 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCAG00010018403
Gene Symbol: BDKRB2
1 Cross references
244 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCAG00010018407
Gene Symbol: BDKRB2
1 Cross references
244 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSLCAG00010002173
Gene Symbol: BDKRB2
4 Cross references
155 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSLCAG00010001869
Gene Symbol: LOC108893416
3 Cross references
193 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSLCAG00010000865
Gene Symbol: LOC108883825
3 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).